Life sciences developer Breakthrough Properties has bought the 1.7-acre Trinity House site on Oxford Business Park from a joint venture between Devonshire House Commercial and Lateral Investment Management.
Breakthrough, a jv between Tishman Speyer and Bellco Capital, aims to create a purpose-built, class-A office and lab scheme on the site.
The Trinity House acquisition adds to Breakthrough’s global pipeline of development projects, which also includes The 105, a 263,500 sq ft life sciences facility in Boston, Massachusetts, fully leased to CRISPR Therapeutics, and Torrey View, a 10-acre campus in San Diego, California, prelet to BD Biosciences.
Thomas Renn, Breakthrough’s vice president of acquisitions and development in Europe, said: “Trinity House represents a great opportunity for us to move quickly to bring the Breakthrough platform to the Golden Triangle, where there is a significant need for high-quality lab provision to meet the growth of the cluster.”
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
See which agents are doing the most investment deals with our On-Demand Rankings >>
